Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA

Abstract

Innate immune defences are essential for the control of virus infection and are triggered through host recognition of viral macromolecular motifs known as pathogen-associated molecular patterns (PAMPs)1. Hepatitis C virus (HCV) is an RNA virus that replicates in the liver, and infects 200 million people worldwide2. Infection is regulated by hepatic immune defences triggered by the cellular RIG-I helicase. RIG-I binds PAMP RNA and signals interferon regulatory factor 3 activation to induce the expression of interferon-α/β and antiviral/interferon-stimulated genes (ISGs) that limit infection3,4,5,6,7,8,9,10. Here we identify the polyuridine motif of the HCV genome 3′ non-translated region and its replication intermediate as the PAMP substrate of RIG-I, and show that this and similar homopolyuridine or homopolyriboadenine motifs present in the genomes of RNA viruses are the chief feature of RIG-I recognition and immune triggering in human and murine cells8. 5′ terminal triphosphate on the PAMP RNA was necessary but not sufficient for RIG-I binding, which was primarily dependent on homopolymeric ribonucleotide composition, linear structure and length. The HCV PAMP RNA stimulated RIG-I-dependent signalling to induce a hepatic innate immune response in vivo, and triggered interferon and ISG expression to suppress HCV infection in vitro. These results provide a conceptual advance by defining specific homopolymeric RNA motifs within the genome of HCV and other RNA viruses as the PAMP substrate of RIG-I, and demonstrate immunogenic features of the PAMP–RIG-I interaction that could be used as an immune adjuvant for vaccine and immunotherapy approaches.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Identification of HCV PAMP RNA.
Figure 2: RIG-I-specific HCV RNA PAMP recognition and signalling.
Figure 3: Polyuridine and polyriboadenine ribonucleotides are RIG-I ligands.
Figure 4: HCV PAMP RNA triggers the hepatic innate immune response and anti-HCV defences.

Similar content being viewed by others

References

  1. Saito, T. & Gale Jr., M. Principles of intracellular viral recognition. Curr. Opin. Immunol. 19, 17–23 (2007)

    Article  CAS  Google Scholar 

  2. Lauer, G. M. & Walker, B. D. Medical progress: Hepatitis C virus infection. N. Engl. J. Med. 345, 41–52 (2001)

    Article  CAS  Google Scholar 

  3. Gale Jr., M. & Foy, E. M. Evasion of intracellular host defence by hepatitis C virus. Nature 436, 939–945 (2005)

    Article  ADS  Google Scholar 

  4. Sumpter, R. et al. Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J. Virol. 79, 2689–2699 (2005)

    Article  CAS  Google Scholar 

  5. Hornung, V. et al. 5'-triphosphate RNA is the ligand for RIG-I. Science 314, 994–997 (2006)

    Article  ADS  Google Scholar 

  6. Pichlmair, A. et al. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates. Science 314, 997–1001 (2006)

    Article  CAS  ADS  Google Scholar 

  7. Yoneyama, M. et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nature Immunol. 5, 730–737 (2004)

    Article  CAS  Google Scholar 

  8. Loo, Y. M. et al. Distinct RIG-I and MDA5 signaling regulation by RNA viruses in innate immunity. J. Virol. 27, 697 (2007)

    Google Scholar 

  9. Lau, D. T. et al. Interferon regulatory factor-3 activation, hepatic interferon-stimulated gene expression, and immune cell infiltration in hepatitis C virus patients. Hepatology 47, 799–809 (2008)

    Article  CAS  Google Scholar 

  10. Smith, M. W. et al. Gene expression patterns that correlate with hepatitis C and early progression to fibrosis in liver transplant recipients. Gastroenterology 130, 179–187 (2006)

    Article  CAS  Google Scholar 

  11. Simmonds, P. Genetic diversity and evolution of hepatitis C virus - 15 years on. J. Gen. Virol. 85, 3173–3188 (2004)

    Article  CAS  Google Scholar 

  12. Kolykhalov, A. A., Mihalik, K., Feinstone, S. M. & Rice, C. M. Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3 ' nontranslated region are essential for virus replication in vivo . J. Virol. 74, 2046–2051 (2000)

    Article  CAS  Google Scholar 

  13. Yi, M. K. & Lemon, S. M. 3' Nontranslated RNA signals required for replication of hepatitis C virus RNA. J. Virol. 77, 3557–3568 (2003)

    Article  CAS  Google Scholar 

  14. Honda, M. et al. Structural requirements for initiation of translation by internal ribosome entry within genome-length hepatitis C virus RNA. Virology 222, 31–42 (1996)

    Article  CAS  Google Scholar 

  15. Kato, H. et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441, 101–105 (2006)

    Article  MathSciNet  CAS  ADS  Google Scholar 

  16. Heil, F. et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303, 1526–1529 (2004)

    Article  CAS  ADS  Google Scholar 

  17. Saito, T. et al. Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proc. Natl Acad. Sci. USA 104, 582–587 (2007)

    Article  CAS  ADS  Google Scholar 

  18. Takahasi, K. et al. Nonself RNA-sensing mechanism of RIG-I helicase and activation of antiviral immune responses. Mol. Cell 29, 428–440 (2008)

    Article  CAS  Google Scholar 

  19. Cui, S. et al. The C-terminal regulatory domain is the RNA 5′-triphosphate sensor of RIG-I. Mol. Cell 29, 169–179 (2008)

    Article  CAS  Google Scholar 

  20. Marques, J. T. et al. A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells. Nature Biotechnol. 24, 559–565 (2006)

    Article  CAS  Google Scholar 

  21. You, S. & Rice, C. M. 3′ RNA elements in hepatitis C virus replication: kissing partners and long poly(U). J. Virol. 82, 184–195 (2008)

    Article  CAS  Google Scholar 

  22. Ito, T. & Lai, M. M. C. An internal polypyrimidine-tract-binding protein-binding site in the hepatitis C virus RNA attenuates translation, which is relieved by the 3'-untranslated sequence. Virology 254, 288–296 (1999)

    Article  CAS  Google Scholar 

  23. Kim, D. H. et al. Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase. Nature Biotechnol. 22, 321–325 (2004)

    Article  CAS  Google Scholar 

  24. Afonina, E., Stauber, R. & Pavlakis, G. N. The human Poly(A)-binding protein 1 shuttles between the nucleus and the cytoplasm. J. Biol. Chem. 273, 13015–13021 (1998)

    Article  CAS  Google Scholar 

  25. Yusupov, M. M. et al. Crystal structure of the ribosome at 5.5 Å resolution. Science 292, 883–896 (2001)

    Article  CAS  ADS  Google Scholar 

  26. Meylan, E. et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437, 1167–1172 (2005)

    Article  CAS  ADS  Google Scholar 

  27. Loo, Y. M. et al. Viral and therapeutic control of IFN-β promoter stimulator 1 during hepatitis C virus infection. Proc. Natl Acad. Sci. USA 103, 6001–6006 (2006)

    Article  CAS  ADS  Google Scholar 

  28. Tse, K. & Horner, A. A. Update on toll-like receptor-directed therapies for human disease. Ann. Rheum. Dis. 66 (suppl. 3). 77–80 (2007)

    Article  Google Scholar 

  29. Beard, M. R. et al. An infectious molecular clone of a Japanese genotype 1b hepatitis C virus. Hepatology 30, 316–324 (1999)

    Article  CAS  Google Scholar 

  30. Takaoka, A. et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448, 501–505 (2007)

    Article  CAS  ADS  Google Scholar 

Download references

Acknowledgements

We thank T. Fujita for discussions, and S. Horner for manuscript review. We thank T. Fujita, S. Lemon, G. Sen, C. Rice, T. Taniguchi, A. Miyawaki, S. Akira for reagents, R. Hirai for technical consultation, and J. Briley, S. Thomas and G. Martin for technical assistance. This work was supported by funds from the State of Washington, National Institutes of Health grants R01AI060389, R01DA021353, U19AI40035 (Project 4) and the Burroughs-Wellcome Fund, and by a gift from Mr. and Mrs. R. Batcheldor.

Author Contributions T.S. conducted RNA binding studies and RIG-I signalling analyses. T.S. and D.M.O. conducted in vivo studies. F.J. and J.M. developed the RIG-I protein-expression system, and produced, purified and tested recombinant RIG-I proteins. M.G. directed the research. All authors participated in study design and manuscript preparation. T.S. wrote the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michael Gale Jr..

Supplementary information

Supplementary Information

The file contains Supplementary Methods, Supplementary Tables S1-S2 and Supplementary Figures S1-S7 with legends and additional references. (PDF 1189 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Saito, T., Owen, D., Jiang, F. et al. Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature 454, 523–527 (2008). https://doi.org/10.1038/nature07106

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nature07106

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing